#viral persistence — Monday, August 31, 2026 (1 items)
| 3 | 💬 0 |
Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases 2026-08-31 | #long covid #covid-19 #clinical trial #antiviral #viral persistence |